🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Multicenter Trial of Proximal Femoral Guided Growth in Children With CP and Hips at Risk of Dislocation (GGSH-MC)

RecruitingNAAges 3 Years - 8 YearsAllFundación para la investigación biomética Hospita…
NCT06956729 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The Guided Growth in Spastic Hip Multicenter Study (GGSH-MC) is a prospective, multicenter, randomized controlled trial that aims to evaluate the mid-term outcomes of Proximal Femoral Guided Growth (PFGG) in children with spastic cerebral palsy (CP) and hips at risk of dislocation (HRD). Hip dislocation is a common and severe complication in children with CP, especially those who are non-ambulatory, with a reported risk of 70-90%. The trial includes children aged 3 to 8 years with spastic CP and HRD, defined by a migration percentage (MP) between 30% and 60%. Participants will be cluster-randomized by center into two parallel groups: * Experimental Group: Standard prophylactic treatment for HRD + PFGG * Control Group: Standard prophylactic treatment for HRD only PFGG involves insertion of a fully threaded cannulated screw across the lateral cortex and proximal femoral epiphysis under

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patients aged 3 to 8 years. * Diagnosis of predominantly spastic cerebral palsy (CP). * Any functional level according to the GMFCS. * Hips at risk of dislocation (HRD), unilateral or bilateral, defined by a migration percentage (MP) between 30% and 60%. Exclusion Criteria: * Children with predominantly hypotonic or dystonic types of CP. * Children with neuromuscular conditions other than CP. * Children with high surgical/anesthetic risk. * Documented history of reconstructive or palliative hip surgery.
💊

What it tests

  • Proximal Femoral Guided Growth.
  • Standard prophylactic treatment for Hips at Risk of Dislocation.
📍

Where

16 sites
H. Materno Inf. Teresa Herrera
A Coruña, Spain
Hospital Universitario Torrecárdenas Almeria
Almería, Spain
H.U. Virgen Macarena Sevilla
Seville, Spain
H.U. Virgen Del Rocio
Seville, Spain
Ihp-Orthopediatica Sevilla
Seville, Spain
H. Universitari Son Espases
Palma, Spain
H. Universitario de Salamanca
Salamanca, Spain
H. Sant Joan de Deu
Barcelona, Spain

…and 8 more on ClinicalTrials.gov.

🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy